Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS)

Prolonged‐release fampridine (fampridine PR) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine PR has been approved to improve speed of walking in patients with multiple sclerosis. This statement provides a brief summary o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CNS Neurosci Ther
Egile Nagusiak: Preiningerova, Jana Lizrova, Baumhackl, Ulf, Csepany, Tunde, Czaplinski, Adam, Deisenhammer, Florian, Derfuss, Tobias, Fabjan, Tanja H., Fazekas, Franz, Fuchs, Siegrid, Havrdova, Eva, Ledinek, Alenka Horvath, Illes, Zsolt, Jazbec, Sasa Sega, Klimova, Eleonora, Komoly, Samuel, Kurca, Egon, Linnebank, Michael, Lisy, Lubomir, Mares, Jan, Prochazkova, Lubica, Csilla, Rozsa, Szilasiova, Jarmila, Stourac, Pavel, Talab, Radomir, Turcani, Peter, Vachova, Marta, Vecsei, Laszlo, Vodusek, David, Zapletalova, Olga, Berger, Thomas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2013
Gaiak:
Clinical Guidelines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493348/
https://ncbi.nlm.nih.gov/pubmed/23607697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12101
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak